Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.52 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.52 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.52 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.52 |
| ▸ | P2RY6 | Q15077 | 10/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 14/20 | 0.49 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.49 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.48 |
| ▸ | TYMP | P19971 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6323744 | 1.00 | SLC28A1 (0.52) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL6323748 | 1.00 | SLC28A1 (0.52) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL7922851 | 1.00 | SLC28A1 (0.52) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL4085510 | 0.90 | SLC28A1 (0.62) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8332109 | 0.90 | SLC28A1 (0.62) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2584027 | 0.86 | SLC28A1 (0.52) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL3316264 | 0.85 | P2RY14 (0.51) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2580691 | 0.84 | P2RY2 (0.49) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL7257091 | 0.83 | TYMP (0.47) | TYMP | |
| SCHEMBL7257093 | 0.83 | TYMP (0.47) | TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6214551-B1 | CONTACTING TEST SOLUTION CONTAINING NUCLEIC ACID WITH COMPOUND CONTAINING NUCLEOSIDE SEQUENCE WHEREIN NUCLEOSIDES ARE COVALENTLY BOUND THROUGH LINKING GROUP HAVING ADJACENT NITROGEN ATOMS FOR ASSAYING SEQUENCE-SPECIFIC NUCLEIC ACID | ISIS PHARMACEUTICALS, INC. | 2001-04-10 | — | — | US | disclosed |